Shares of dental and medical products company Henry Schein (NASDAQ:HSIC)
fell 9.7% in the afternoon session after the company reported second-quarter earnings that missed profit expectations and showed a year-over-year decline.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs. FY2025 guidance affirmed.
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. The positive sentiment swept across markets after it was announced the U.S. and Japan had reached a new trade deal. The agreement included a 15% tariff on Japanese goods imported into the U.S. and a commitment from Japan to invest $550 billion in the U.S. and open its markets to American cars and agricultural products. This development boosted investor confidence and contributed to a widespread rally, lifting stocks across many sectors. The Dow Jones Industrial Average and the S&P 500 both posted gains, creating a favorable environment that likely benefited individual stocks.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC)
fell 3.5% in the afternoon session after an analyst at Baird downgraded the stock and cut its price target, citing the potential loss of a major customer. The investment firm lowered its rating on the healthcare products distributor to "Neutral" from "Outperform" and slashed its price target to $72 from $82. The downgrade was prompted by concerns that Heartland Dental, described as Henry Schein's largest global customer, might not renew its contract, which is estimated to be worth around $100 million annually. According to Baird, while the direct financial hit may be manageable, the move could set a precedent for other large customers to seek direct agreements with manufacturers. This possibility creates a potential "overhang" on the stock, which could weigh on its performance in the near to medium term. The negative sentiment was also reflected in the stock's technicals, as shares crossed below their 200-day moving average, a key technical indicator often watched by traders.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 6%. This drop is a stark contrast from the S&P 500’s 7.5% gain.
